[HTML][HTML] Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
[HTML][HTML] COVID-19: characteristics and therapeutics
R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …
December 2019 is still haunting the entire human race and has affected not only the …
COVID-19 therapeutics: Challenges and directions for the future
PC Robinson, DFL Liew, HL Tanner… - Proceedings of the …, 2022 - National Acad Sciences
The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …
Tackling SARS-CoV-2: proposed targets and repurposed drugs
The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …
A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29
SPH Alexander, JF Armstrong… - British journal of …, 2020 - Wiley Online Library
In this review, we identify opportunities for drug discovery in the treatment of COVID‐19 and,
in so doing, provide a rational roadmap whereby pharmacology and pharmacologists can …
in so doing, provide a rational roadmap whereby pharmacology and pharmacologists can …
Old drugs for a new virus: repurposed approaches for combating COVID-19
S Saul, S Einav - ACS infectious diseases, 2020 - ACS Publications
There is a large global unmet need for effective countermeasures to combat severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus …
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus …
[HTML][HTML] Drug targets for COVID-19 therapeutics: Ongoing global efforts
A Saxena - Journal of biosciences, 2020 - Springer
The current global pandemic COVID-19 caused by the SARS-CoV-2 virus has already
inflicted insurmountable damage both to the human lives and global economy. There is an …
inflicted insurmountable damage both to the human lives and global economy. There is an …
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
G Li, E De Clercq - Nature reviews Drug discovery, 2020 - nature.com
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
Abstract Coronavirus disease‐19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), is one of the most contagious diseases in human …
syndrome coronavirus 2 (SARS‐CoV‐2), is one of the most contagious diseases in human …
[HTML][HTML] The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …